The Max Delbrück Center and the Berlin Institute of Health at Charité have joined a national network of six genome computing centers and the German Human Genome Phenome Archive. This makes Berlin an operational data hub for genome medicine and omics-based research. 

A research team involving the Hannover Medical School (MHH), the German Primate Center – Leibniz Institute for Primate Research (DPZ), as well as the Max Plank Institute for Molecular Cell Biology and Genetics has used human brain organoids to investigate how changes in important structural proteins in the cell lead to severe developmental disorders such as microcephaly.

As part of the GO-Bio initial program of the Federal Ministry of Research, Technology, and Space (BMFTR), a project is being funded that develops patient organoids to identify treatment options for childhood liver diseases. 

MPS World Summit 2026: Call for abstracts

Friday, 12 December 2025 16:40

The Microphysiological Systems World Summit will take place again from May 26 to 29, 2026, this time in Washington, DC. Abstracts are requested on the following topics:

Siegen: Intestinal bleeding model on a chip

Wednesday, 10 December 2025 12:17

A research team led by Prof. Dr. Maria Brehm, biochemist at the University of Siegen, has developed a 3D disease model of the intestine on a microchip. It is being used to investigate the role of von Willebrand factor in the development of intestinal bleeding.

Researchers can apply for the Saarland Research Award for Alternatives to Animal Testing until January 9. The award is endowed with €10,000.

PFAS impair placental function

Friday, 05 December 2025 12:59

Using a 3D placental model, researchers at the Helmholtz Centre for Environmental Research (UFZ) in cooperation with Dessau Municipal Hospital have discovered that PFAS, also known as persistent chemicals, disrupt the functionality of the placenta. This can increase the risk of miscarriage.

JRC publishes database on animal-free methods

Wednesday, 03 December 2025 13:07

Long awaited – now it's here: the BimmoH (BioMed Model Hub) database has been made available. It can be used to find information on models relevant to humans that are used in biomedical research.
 

The pharmaceutical company Merck KGaA is developing a new drug to treat Parkinson's disease. To this end, it has partnered with the US company Valo Health, focusing on artificial intelligence.

As announced in a recent press release, researchers at the University of Basel have succeeded in replicating the cellular complexity of bone marrow from human cells in the laboratory. As is said, this system could reduce animal testing for many applications.